Coronavirus vaccines– accumulate wealth for Shareholders

Updated: Dec 16, 2020

Coronavirus related pressures is expected to ease as vaccines and treatments is expected to reach the market in 2021 in full fledge. This will accumulate wealth to shareholder such as Pfizer Inc., BioNTech, Gilead Sciences, Eli Lilly and Regeneron Pharmaceutical Inc because these companies are keeping drugs price at profit.

For more details please contact info@eliteageresearch.com